Tuesday, April 24, 2018
By PR Newswire
TAICANG, China, April 24, 2018 /PRNewswire/ -- Connect Biopharmaceuticals, Ltd. today announced that it has submitted an application in Australia to begin a phase 1 clinical trial to evaluate CBP-201, the company's monoclonal antibody candidate for allergic inflammation.   [READ MORE]

MENLO PARK, Calif. and SOUTH PLAINFIELD, N.J., April 24, 2018 /PRNewswire/ -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leader in long-read, high-resolution sequencing, and   [READ MORE]
WASHINGTON, April 24, 2018 /PRNewswire/ -- For National Asthma and Allergy Awareness Month, USA Medical recognizes the 25 million people in America who suffer from these diseases. The Company offers assistance by providing discounts on medications prescribed for asthma and allergies through it.....   [READ MORE]

BEIJING, April 23, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac " or the "Company"), a leading provider of biopharmaceutical products in China, today announced that hepatitis A vaccine and seasonal flu vaccine production has resumed at the Shangdi manufactur.....   [READ MORE]

PORTLAND, Ore., April 23, 2018 /PRNewswire/ -- WebMD Health Services, a subsidiary of WebMD Health Corp., has earned two industry-leading accreditations for its well-being and disease management programs and a certification for its health information products from the National Committee for Quality Assurance (NCQA).   [READ MORE]
PITTSBURGH, April 17, 2018 /PRNewswire/ -- Highmark Inc. has entered into an outcomes-based contract with AstraZeneca for the well-known medicine Symbicort®. Indicated for the treatment of asthma and chronic obstructive pulmonary disease (COPD), Symbicort helps decrease inflammation and open up the airways.....   [READ MORE]

About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines